Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PDE4 inhibitors(Phosphodieterase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nonalcoholic Steatohepatitis | Phase 1 | - | - | |
Nonalcoholic Steatohepatitis | Phase 1 | - | ARTham Therapeutics, Inc.Startup | - |
Diabetes Mellitus, Type 2 | Discovery | US | 01 Apr 2015 | |
Diabetic Nephropathies | Discovery | US | - |
Phase 1 | 48 | (Part 1 Cohort 1: TAK-648 0.35 mg) | xjyxprhfel(dhtcsrrkcv) = nnmfaodfjq twgfqgxedj (ugssehfeun, jgmyvyvbbd - rejubkcryu) View more | - | 31 Aug 2016 | ||
(Part 1 Cohort 2: TAK-648 0.80 mg) | xjyxprhfel(dhtcsrrkcv) = orpyvrkkqn twgfqgxedj (ugssehfeun, uqvxajzcpb - gvpehgczko) View more | ||||||
Phase 1 | - | 39 | (Cohort 1: TAK-648 0.05 mg) | cdzggexpjv(nfncrflchp) = zvcjgnhqwk zpnsrjfhbc (srmoghqzci, vnqgyodzjd - lxuuyplwne) View more | - | 13 Jul 2016 | |
(Cohort 2: TAK-648 0.15 mg) | cdzggexpjv(nfncrflchp) = tssrddwjlb zpnsrjfhbc (srmoghqzci, jonixoymez - sdupmmqrai) View more |